Home
Solutions
Beacon ADC
Beacon Adoptive Cell
Beacon Bispecific
Beacon Cancer Vaccine
Beacon Checkpoint
Beacon Cytokine
Beacon DDR
Beacon Gene Therapy
Beacon Microbiome
Beacon RNA
Beacon Oncolytic Viruses
Beacon TPD
About
News
Events
Resources
Contact
Login
Site Map
Content Types
Posts
New day for antibody-drug conjugates – Chemical & Engineering News
What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt
Beacon Targeted Therapies announces the launch of Beacon Oncolytic Viruses
Cell Therapy 2.0
Overcoming Challenges in the Development of Anticancer ADCs
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade
Beacon Targeted Therapies announces the launch of Beacon Gene Therapy
Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
Hot Topics at CAR-TCR 2020
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials
TCR Therapies Summit 2020 Magazine
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
CAR-TCR Europe Summit 2020 Magazine
World ADC London 2020 Magazine
Innate Killer Summit 2020 Magazine
From Mylotarg to Polivy: Ebbs and flows, successes and woes of ADCs
Trends & Forecasts – Tenacious ADCs
World ADC San Diego Magazine 2019
Beacon Targeted Therapies expands on Adoptive Cell Clinical Trial and Drug Database Solutions
Biomarkers for Checkpoint Inhibition and Their Clinical Utility – Timothy James Fabisiak, B.A.
Bispecific antibodies: a mechanistic review of the pipeline Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert & Paul W. H. I. Parren
Beacon Targeted Therapies Launches Beacon Adoptive Cell
The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand – Charlie Johnson, CEO of ADC Bio, adcbio.com
Antibodies to watch in 2019 – Hélène Kaplon & Janice M. Reichert
Pages
Our data charter
FAQS
Advanced Keyword Searches
News
Solutions
Request a demo
About
Contact
Events
Who’s it for
Privacy
Resources
Site Map
Terms & Conditions
Home
Solutions
Beacon Microbiome
Beacon RNA
Beacon Cytokine
Beacon Cancer Vaccine
Beacon TPD
Beacon DDR
Beacon Oncolytic Viruses
Beacon Gene Therapy
Beacon Checkpoint
Beacon Bispecific
Beacon Adoptive Cell
Beacon ADC
Events
Non-Small Cell Lung Cancer Drug Development Summit 2022
13th World ADC San Diego 2022
13th World Multispecifics Summit 2022
3rd Gamma Delta T Therapies Summit
3rd Cytokine-Based Drug Development Summit 2022
4th Cell Engager Summit 2022
12th World ADC London 2022
Gene Therapy for Rare Disorders 2022
Next Generation CAR-TCR Summit 2022
LAG-3 Targeted Drug Development Summit 2022
2nd Annual TIGIT Therapies Summit 2021
DDR, ATR & PARP Inhibitors Summit 2022
Cytokine-Based Cancer Immunotherapies Summit
4th Targeted Protein Degradation Summit
12th World ADC San Diego -The Digital Edition
Previous Event
6th Annual CAR-TCR Summit
Next Generation Cancer Vaccine Development Summit
12th Annual World Bispecific Summit
Webinars
Beacon Cancer Vaccine Webinar 2022
DDR Webinar 2022
TPD Webinar 2021
Oncolytic Viruses Webinar 2021
Gene Therapy Webinar 2021
Adoptive Cell Webinar 2021
Oncolytic Viruses Webinar 2020
Bispecific Webinar 2020
ADC Webinar 2020
Gene Therapy Webinar 2020
Infographics
Microbiome Movement Drug Development Presentation
Checkpoint ASCO Post-Conference Report 2022
Cytokine ASCO Post-Conference Report 2022
Bispecific ASCO Post-Conference Report 2022
DDR ASCO Post-Conference Report 2022
ADC ASCO Post-Conference Report 2022
Oncolytic Viruses – Vaccinia Virus Analysis
Adoptive Cell – Manufacturing Challenges & Considerations for Allogeneic Cell Therapy
Adoptive Cell ASGCT Post-Conference Report 2022
Gene Therapy ASGCT Post-Conference Report 2022
Cancer Vaccine ASCO Pre-Conference Planner 2022
TPD Beacon Podcast Ep.1
DDR ASCO Pre-Conference Planner 2022
Gene Therapy ASGCT Pre-Conference Planner 2022
RNA ASGCT Pre-Conference Planner 2022
TPD ASCO Pre-Conference Planner 2022
Cytokine ASCO Pre-Conference Planner 2022
Bispecific ASCO Pre-Conference Planner 2022
Checkpoint ASCO Pre-Conference Planner 2022
RNA AACR Post-Conference Planner 2022
ADC ASCO Pre-Conference Planner 2022
Oncolytic Viruses ASCO Pre-Conference Planner 2022
Adoptive Cell ASCO Pre-Conference Planner 2022
The Thriving Interleukin Therapies Landscape: Clinical and Preclinical Key Developments
DDR AACR Infographic 2022
The CD73 Cancer Clinical Trial Landscape
Adoptive Cell AACR Post-Conference Report 2022
Oncolytic Viruses AACR Post-Conference Report 2022
Cancer Vaccine AACR Post-Conference Report 2022
TPD AACR Post-Conference Report 2022
Cytokine AACR Post-Conference Report 2022
Bispecific AACR Post-Conference Report 2022
ADC AACR Post-Conference Report 2022
Checkpoint AACR Post-Conference Report 2022
The RNA Landscape and Beyond Presentation
Gene Therapy AAV Durability Report
RNA AACR Pre-Conference Planner 2022
Adoptive Cell AACR Pre-Conference Planner 2022
Cancer Vaccine AACR Pre-Conference Planner 2022
Checkpoint AACR Pre-Conference Planner 2022
Bispecific AACR Pre-Conference Planner 2022
Cytokine AACR Pre-Conference Planner 2022
ADC AACR Pre-Conference Planner 2022
TPD AACR Pre-Conference Planner 2022
Oncolytic Viruses AACR Pre-Conference Planner 2022
DDR AACR Pre-Conference Planner 2022
RNA Infographic 2022
Landscape Reviews
DDR Interview Dec 2021
TPD Infographic 2021
RNA Infographic 2021
ADC Infographic 2021
Cytokine Infographic 2021
ADC Infographic 2021
Cancer Vaccine Infographic 2021
Gene Therapy Infographic 2021
DDR Infographic June 2021
Oncolytic Viruses Infographic 2021
TPD Infographic 2021
Bispecific Infographic 2021
Adoptive Cell Infographic 2021
DDR Infographic 2021
Checkpoint Thought Paper 2020
Adoptive Cell Infographic 2020
Bispecific Infographic 2020
Checkpoint Infographic 2020
Gene Therapy Infographic 2020
ADC Infographic 2020
Oncolytic Viruses Infographic 2020
Bispecific and Checkpoint Infographic 2020
Archives
Categories
ADC
Adoptive Cell
Bispecific
Cancer Vaccine
Checkpoint
Cytokine
DDR
Gene Therapy
Infographic
Infographic
Microbiome
Oncolytic Viruses
RNA
Thought Paper
TPD
Uncategorized
Webinar
Home
Solutions
Beacon ADC
Beacon Adoptive Cell
Beacon Bispecific
Beacon Cancer Vaccine
Beacon Checkpoint
Beacon Cytokine
Beacon DDR
Beacon Gene Therapy
Beacon Microbiome
Beacon RNA
Beacon Oncolytic Viruses
Beacon TPD
About
News
Events
Resources
Contact
Login
This is the brochure-popup
This is the contact us popup